| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1997PNAS...94.8970G |
| P356 | DOI | 10.1073/PNAS.94.17.8970 |
| P932 | PMC publication ID | 22989 |
| P698 | PubMed publication ID | 9256419 |
| P5875 | ResearchGate publication ID | 13964599 |
| P2093 | author name string | P M Kloetzel | |
| R Stohwasser | |||
| M Groettrup | |||
| S Standera | |||
| P2860 | cites work | cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y | Q24317539 |
| Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma | Q24322943 | ||
| Structure and functions of the 20S and 26S proteasomes | Q24328777 | ||
| Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis | Q24561722 | ||
| Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution | Q27730197 | ||
| Structure of 20S proteasome from yeast at 2.4 A resolution | Q27735081 | ||
| Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly | Q27931608 | ||
| A tight cluster of five unrelated human genes on chromosome 16q22.1 | Q28257685 | ||
| Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins | Q28305317 | ||
| Structure of peptides associated with MHC class I molecules. | Q30463852 | ||
| Proteasome from Thermoplasma acidophilum: a threonine protease | Q34309062 | ||
| Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. | Q35772675 | ||
| Sorting out the cytokines of asthma | Q36366166 | ||
| Generation, translocation, and presentation of MHC class I-restricted peptides | Q40422033 | ||
| Supply and transport of peptides presented by class I MHC molecules | Q40540071 | ||
| Peptides naturally presented by MHC class I molecules | Q40898177 | ||
| Peptide antigen production by the proteasome: complexity provides efficiency | Q41149916 | ||
| The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro | Q41283840 | ||
| LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. | Q41320609 | ||
| Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport | Q41371575 | ||
| 20 S proteasomes are assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins takes place in 13-16 S preproteasome complexes | Q41481469 | ||
| T cell receptor (TCR) beta chain homodimers on the surface of immature but not mature alpha, gamma, delta chain deficient T cell lines | Q41529750 | ||
| The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulate | Q41533729 | ||
| Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules | Q41594402 | ||
| Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid | Q42152736 | ||
| PRE3, highly homologous to the human major histocompatibility complex-linked LMP2 (RING12) gene, codes for a yeast proteasome subunit necessary for the peptidylglutamyl-peptide hydrolyzing activity | Q48084093 | ||
| Altered peptidase and viral-specific T cell response in LMP2 mutant mice. | Q52508504 | ||
| A third interferon-gamma-induced subunit exchange in the 20S proteasome. | Q53007185 | ||
| MHC class I expression in mice lacking the proteasome subunit LMP-7 | Q57198383 | ||
| Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit | Q71483389 | ||
| Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ | Q71815183 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8970-8975 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome | |
| P478 | volume | 94 |
| Q33677593 | 20S immunoproteasomes remove formaldehyde-damaged cytoplasmic proteins suppressing caspase-independent cell death |
| Q33941912 | 20S proteasome biogenesis |
| Q36960167 | A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction |
| Q39454661 | Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1. |
| Q40629607 | Alpha-ring Independent Assembly of the 20S Proteasome |
| Q99571197 | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model |
| Q33536525 | Antigen presentation by MHC class I and its regulation by interferon gamma |
| Q34193262 | Antigen processing by the proteasome |
| Q34161423 | Beta 2 subunit propeptides influence cooperative proteasome assembly |
| Q47139212 | Change in the Content of Immunoproteasomes and Macrophages in Rat Liver At the Induction of Donor-Specific Tolerance |
| Q50704066 | Changes in proteasome chymotrypsin-like activity during the development of human mammary and thyroid carcinomas. |
| Q35944320 | Changes in the Proteasome Pool during Malignant Transformation of Mouse Liver Cells |
| Q40602889 | Characterization of the Interaction between the Matrix Protein of Vesicular Stomatitis Virus and the Immunoproteasome Subunit LMP2. |
| Q52914124 | Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients. |
| Q89985249 | Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome |
| Q33701031 | Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome |
| Q35108299 | Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1. |
| Q52321810 | Defective immuno- and thymoproteasome assembly causes severe immunodeficiency. |
| Q34122227 | Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. |
| Q36201122 | Denervation-Induced Activation of the Standard Proteasome and Immunoproteasome |
| Q42378494 | Detection of active proteasome structures in brain extracts: proteasome features of August rat brain with violations in monoamine metabolism |
| Q44303570 | Differential expression of ubiquitin and proteasome-dependent pathway components in rat tissues. |
| Q40859882 | Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28 |
| Q32067271 | Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome |
| Q92972669 | Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation |
| Q37711312 | Effects of ethanol on the proteasome interacting proteins |
| Q36375899 | Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes |
| Q35555565 | Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes |
| Q38837519 | Emerging role of immunoproteasomes in pathophysiology |
| Q36143622 | Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer |
| Q36149832 | Ethanol and hepatitis C virus suppress peptide-MHC class I presentation in hepatocytes by altering proteasome function |
| Q53609777 | Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity. |
| Q35821221 | Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. |
| Q96135902 | Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells |
| Q24531439 | IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response |
| Q36381008 | Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits |
| Q21133685 | Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling |
| Q35610769 | Immunoproteasome deficiency protects in the retina after optic nerve crush. |
| Q30894991 | Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice |
| Q35637495 | Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders |
| Q41497500 | Immunoproteasomes edit tumors, which then escapes immune recognition |
| Q27024527 | Immunoproteasomes: structure, function, and antigen presentation |
| Q34169329 | Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells |
| Q41034976 | Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. |
| Q50072067 | Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells |
| Q36347192 | Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke. |
| Q39454584 | Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection |
| Q34214158 | Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? |
| Q36266425 | Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing |
| Q40851962 | Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28. |
| Q26866479 | MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells |
| Q34801810 | MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation |
| Q36583731 | Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma. |
| Q27693890 | Molecular architecture and assembly of the eukaryotic proteasome |
| Q48079139 | Molecular characterization, expression and mapping of porcine LMP2 and MECL-1 genes |
| Q37610453 | Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation |
| Q34928594 | Molecular mechanisms of proteasome assembly |
| Q40940981 | Mutational analysis of subunit i beta2 (MECL-1) demonstrates conservation of cleavage specificity between yeast and mammalian proteasomes. |
| Q50498749 | Native structure of rat liver immune proteasomes. |
| Q42871391 | Ontogenesis of rat immune system: Proteasome expression in different cell populations of the developing thymus |
| Q24540374 | PI31 is a modulator of proteasome formation and antigen processing |
| Q39978475 | Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis |
| Q47704805 | Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms. |
| Q43824380 | Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation |
| Q23919487 | Proteasomal interference prevents zona pellucida penetration and fertilization in mammals |
| Q28245575 | Proteasome assembly |
| Q36260235 | Proteasome function is not impaired in healthy aging of the lung |
| Q34362098 | Proteasome functioning in breast cancer: connection with clinical-pathological factors |
| Q38269935 | Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex |
| Q38255471 | Proteasome- and ethanol-dependent regulation of HCV-infection pathogenesis |
| Q92923068 | Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer |
| Q100678665 | Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis |
| Q37188091 | Role of proteasomes in cellular regulation |
| Q35860867 | SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model |
| Q40027466 | Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits |
| Q40678796 | Silencing of Inducible Immunoproteasome Subunit Expression by Chemically Modified siRNA and shRNA. |
| Q27026951 | Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies |
| Q47700046 | The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. |
| Q64166842 | The immunoproteasome and thymoproteasome: functions, evolution and human disease |
| Q27694656 | The immunoproteasome and viral infection: a complex regulator of inflammation |
| Q40317278 | The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2. |
| Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
| Q36483688 | The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion |
| Q38833090 | The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition |
| Q47278714 | The proteasome: a protein-destroying machine |
| Q28219263 | The role of the proteasome activator PA28 in MHC class I antigen processing |
| Q36401780 | The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope |
| Q43181859 | Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation |
| Q34276719 | Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. |
| Q34135115 | Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses |
| Q42565267 | mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress |
Search more.